Literature DB >> 28545321

Virus detection by PCR following vaccination of naive calves with intranasal or injectable multivalent modified-live viral vaccines.

Paul H Walz1,2, Benjamin W Newcomer1,2, Kay P Riddell1,2, Daniel W Scruggs1,2, Victor S Cortese1,2.   

Abstract

We evaluated duration of PCR-positive results following administration of modified-live viral (MLV) vaccines to beef calves. Twenty beef calves were randomly assigned to either group 1 and vaccinated intranasally with a MLV vaccine containing bovine alphaherpesvirus 1 (BoHV-1), bovine respiratory syncytial virus (BRSV), and bovine parainfluenza virus 3 (BPIV-3), or to group 2 and vaccinated subcutaneously with a MLV vaccine containing bovine viral diarrhea virus 1 and 2 (BVDV-1, -2), BoHV-1, BRSV, and BPIV-3. Deep nasopharyngeal swabs (NPS) and transtracheal washes (TTW) were collected from all calves, and whole blood was collected from group 2 calves and tested by PCR. In group 1, the proportions of calves that tested PCR-positive to BVDV, BoHV-1, BRSV, and BPIV-3 on any sample at any time were 0%, 100%, 100%, and 10%, respectively. In group 1 calves, 100% of calves became PCR-positive for BoHV-1 by day 3 post-vaccination and 100% of calves became PCR-positive for BRSV by day 7 post-vaccination. In group 2, the proportions of calves that tested positive to BVDV, BoHV-1, BRSV, and BPIV-3 on any sample at any time were 50%, 40%, 10%, and 0%, respectively. All threshold cycle (Ct) values were >30 in group 2 calves, irrespective of virus; however, Ct values <25 were observed in group 1 calves from PCR-positive results for BoHV-1 and BRSV. All calves were PCR-negative for all viruses after day 28. Following intranasal MLV viral vaccination, PCR results and Ct values for BRSV and BoHV-1 suggest that attempts to differentiate vaccine virus from natural infection is unreliable.

Entities:  

Keywords:  Bovine herpesvirus 1; PCR; bovine parainfluenza virus 3; bovine respiratory syncytial virus; bovine viral diarrhea virus; cattle; deep nasopharyngeal swabs; transtracheal washes; vaccination

Mesh:

Substances:

Year:  2017        PMID: 28545321     DOI: 10.1177/1040638717709039

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  7 in total

1.  Best practices for performance of real-time PCR assays in veterinary diagnostic laboratories.

Authors:  Kathy L Toohey-Kurth; Donna M Mulrooney; Susanne Hinkley; Mary Lea Killian; Janice C Pedersen; Mangkey A Bounpheng; Roman Pogranichniy; Steve Bolin; Roger Maes; Rebecca L Tallmadge; Laura B Goodman; Beate M Crossley
Journal:  J Vet Diagn Invest       Date:  2020-09-30       Impact factor: 1.279

2.  Suggested guidelines for validation of real-time PCR assays in veterinary diagnostic laboratories.

Authors:  Kathy Toohey-Kurth; Monica M Reising; Rebecca L Tallmadge; Laura B Goodman; Jianfa Bai; Steven R Bolin; Janice C Pedersen; Mangkey A Bounpheng; Roman M Pogranichniy; Jane Christopher-Hennings; Mary Lea Killian; Donna M Mulrooney; Roger Maes; Shri Singh; Beate M Crossley
Journal:  J Vet Diagn Invest       Date:  2020-09-28       Impact factor: 1.279

3.  Evaluation of bovine respiratory syncytial virus (BRSV) and bovine herpesvirus (BHV) specific antibody responses between heterologous and homologous prime-boost vaccinated western Canadian beef calves.

Authors:  Nathan E N Erickson; Adam Berenik; Herbert Lardner; Stacey Lacoste; John Campbell; Sheryl Gow; Cheryl Waldner; John Ellis
Journal:  Can Vet J       Date:  2021-01       Impact factor: 1.008

4.  The effect of bovine vaccines against respiratory viruses administered either intranasal or intramuscular on broncho-alveolar fluid cells of heifers.

Authors:  Patricia S Rossi; Rafael I Mattei; Natali R Schllemer; Gabriela R Thomaz; Anna V Antunes; Mauricio P Virmond; Mari J Taube; Heloisa G Bertagnon
Journal:  Vet Q       Date:  2021-12       Impact factor: 3.320

5.  Limitations of bacterial culture, viral PCR, and tulathromycin susceptibility from upper respiratory tract samples in predicting clinical outcome of tulathromycin control or treatment of bovine respiratory disease in high-risk feeder heifers.

Authors:  Jeffrey J Sarchet; John P Pollreisz; David T Bechtol; Mitchell R Blanding; Roger L Saltman; Patrick C Taube
Journal:  PLoS One       Date:  2022-02-10       Impact factor: 3.240

6.  Effectiveness of two intranasal vaccines for the control of bovine respiratory disease in newborn beef calves: A randomized non-inferiority multicentre field trial.

Authors:  N Masset; F Meurens; M Marie; P Lesage; A Lehébel; N Brisseau; S Assié
Journal:  Vet J       Date:  2020-08-19       Impact factor: 2.688

Review 7.  Review on bovine respiratory syncytial virus and bovine parainfluenza - usual suspects in bovine respiratory disease - a narrative review.

Authors:  Birgit Makoschey; Anna Catharina Berge
Journal:  BMC Vet Res       Date:  2021-07-31       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.